Further research has indicated that platelet TGF-β1 deficiency mice can improve ventricular systolic pressure (RVSP) and attenuate pulmonary vascular remodeling from SU5416/hypoxia-induced PAH [80]. The gene discussed is TGFB1; the disease is pulmonary arterial hypertension.